Safety and Clinical Activity of Atezolizumab Plus Ipilimumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Results From a Phase 1b Trial.

Wong, Deborah J; Bauer, Todd M; Gordon, Michael S; Bene-Tchaleu, Fabiola; Zhu, Jing; Zhang, Xiaosong; Cha, Edward

Wong, Deborah J; Bauer, Todd M; Gordon, Michael S; Bene-Tchaleu, Fabiola; Zhu, Jing; Zhang, Xiaosong; Cha, Edward.

Afiliación

Wong DJ; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA. Electronic address: DeWong@mednet.ucla.edu.
Bauer TM; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN.
Gordon MS; HonorHealth Research Institute, Scottsdale, AZ.
Bene-Tchaleu F; F. Hoffmann-La Roche Ltd, Mississauga, ON, Canada.
Zhu J; Genentech, Inc, South San Francisco, CA.
Zhang X; Genentech, Inc, South San Francisco, CA.
Cha E; Genentech, Inc, South San Francisco, CA.

Clin Lung Cancer ; 23(3): 273-281, 2022 05.

Article en En | MEDLINE | ID: mdl-34456145

Asunto(s)

Carcinoma de Pulmón de Células no Pequeñas; Neoplasias Pulmonares; Melanoma; Anticuerpos Monoclonales Humanizados; Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos; Carcinoma de Pulmón de Células no Pequeñas/patología; Humanos; Ipilimumab/uso terapéutico; Neoplasias Pulmonares/patología

Palabras clave

CTLA-4; Checkpoint inhibition; Immunotherapy; PD-L1; Previously treated NSCLC

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares / Melanoma Límite: Humans Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google